FET PET in Neuro-oncology and in Evaluation of Treatment Response

被引：3
作者：
Dunet, Vincent [1 ,2 ]
Prior, John O. [1 ]
机构：
[1] Univ Lausanne Hosp, Dept Nucl Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne Hosp, Dept Radiol, CH-1011 Lausanne, Switzerland
来源：
PET CLINICS | 2013年 / 8卷 / 02期
关键词：
PET; F-18-fluoroethyltyrosine; FET; Amino acid PET; Brain tumor; Glioma;
D O I：
10.1016/j.cpet.2012.09.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Morphologic magnetic resonance imaging is the mainstay in the diagnosis and follow-up of primary brain tumor. However, it has limited ability to differentiate tumor from edema, necrosis, or fibrosis. PET with F-18-fluoro-ethyl-tyrosine (FET) is a promising and complementary diagnostic and prognostic tool to probe tumor biology in vivo. This article presents the tracer biology and uptake mechanism, the imaging protocol and quantitative image analysis, common pitfalls and variants, and the main indications for FET PET. Finally, a summary on what the referring physician needs to know about FET PET is presented.
引用
收藏
页码：147 / +
页数：17
相关论文
共 49 条
  • [1] Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters
    Babu, E
    Kanai, Y
    Chairoungdua, A
    Kim, DK
    Iribe, Y
    Tangtrongsup, S
    Jutabha, P
    Li, YW
    Ahmed, N
    Sakamoto, S
    Anzai, N
    Nagamori, S
    Endou, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) : 43838 - 43845
  • [2] Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading Assessment of Individual Probability of Malignancy
    Calcagni, Maria Lucia
    Galli, Guido
    Giordano, Alessandro
    Taralli, Silvia
    Anile, Carmelo
    Niesen, Andreas
    Baum, Richard Paul
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (10) : 841 - 847
  • [3] Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis
    Dunet, Vincent
    Rossier, Christine
    Buck, Alfred
    Stupp, Roger
    Prior, John O.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (02) : 207 - 214
  • [4] Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma
    Floeth, Frank W.
    Pauleit, Dirk
    Sabel, Michael
    Stoffels, Gabriele
    Reifenberger, Guido
    Riemenschneider, Markus J.
    Jansen, Paul
    Coenen, Heinz H.
    Steiger, Hans-Jakob
    Langen, Karl-Josef
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 519 - 527
  • [5] Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions
    Floeth, Frank Willi
    Sabel, Michael
    Stoffels, Gabriele
    Pauleit, Dirk
    Hamacher, Kurt
    Steiger, Hans-Jakob
    Langen, Karl-Josef
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) : 730 - 737
  • [6] Floeth FW, 2006, J NUCL MED, V47, P776
  • [7] Floeth FW, 2005, J NEUROSURG, V102, P318, DOI 10.3171/jns.2005.102.2.0318
  • [8] Correlation of 6-18F-Fluoro-L-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas
    Fueger, Barbara J.
    Czernin, Johannes
    Cloughesy, Timothy
    Silverman, Daniel H.
    Geist, Cheri L.
    Walter, Martin A.
    Schiepers, Christiaan
    Nghiemphu, Phioanh
    Lai, Albert
    Phelps, Michael E.
    Chen, Wei
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (10) : 1532 - 1538
  • [9] Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
    Galldiks, Norbert
    Langen, Karl-Josef
    Holy, Richard
    Pinkawa, Michael
    Stoffels, Gabriele
    Nolte, Kay W.
    Kaiser, Hans J.
    Filss, Christan P.
    Fink, Gereon R.
    Coenen, Heinz H.
    Eble, Michael J.
    Piroth, Marc D.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (07) : 1048 - 1057
  • [10] PET for radiation treatment planning of brain tumours
    Grosu, Anca-L.
    Weber, Wolfgang A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 (03) : 325 - 327
12345